These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 398497)

  • 1. Membranes and haemodialysis.
    Stephen RL; Zelman A; Scribner BH
    Proc Eur Dial Transplant Assoc; 1979; 16():286-94. PubMed ID: 398497
    [No Abstract]   [Full Text] [Related]  

  • 2. The Donnan effect in artificial kidney therapy.
    Stiller S; Mann H
    Life Support Syst; 1986; 4(4):305-18. PubMed ID: 3561031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta 2-microglobulin kinetics during haemodialysis and haemofiltration.
    Flöge J; Granolleras C; Bingel M; Deschodt G; Branger B; Oules R; Koch KM; Shaldon S
    Nephrol Dial Transplant; 1987; 1(4):223-8. PubMed ID: 3110678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leucopenia, hypoxia and complement activation in haemodialysis. Three unrelated phenomena.
    de Vinuesa SG; Resano M; Luño J; Gonzalez C; Barril G; Junco E; Valderrabano F
    Proc Eur Dial Transplant Assoc; 1983; 19():159-67. PubMed ID: 6878230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellulosic ion-exchange membranes for hemodialysis.
    Mollison AN; Graydon WF
    J Biomed Mater Res; 1977 Jul; 11(4):563-75. PubMed ID: 873946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Regulation of ultrafiltration in plate and coil dialysis apparatus].
    Ragni R; Segoloni GP; Giachino G; Alloatti S; Coppo R; Camussi G; Stratta P; Vercellone A
    Minerva Med; 1974 Nov; 65(84):4372-7. PubMed ID: 4437784
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of solute permeability and rejection characteristics of normal and flux cellulose haemodialysis membranes.
    Klein E; Holland FF; Eberle K
    Proc Eur Dial Transplant Assoc; 1979; 16():198-204. PubMed ID: 548981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Removal of uraemic toxins by haemofiltration with different membranes. The benefit of regenerating haemofiltrate using a newly developed system.
    Jörstad S; Smeby LC; Wideröe TE; Berg KJ
    Proc Eur Dial Transplant Assoc; 1979; 16():212-7. PubMed ID: 548983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemodiafiltration using a polysulfone membrane, its ultrafiltration characteristics and biocompatibility].
    Iarmolinskiĭ IS; Stetsiuk EA; Iarmagomedov AA
    Urol Nefrol (Mosk); 1987; (2):45-9. PubMed ID: 3590419
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma fibronectin concentrations in hemodialyzed patients. Influence of different dialyzers.
    Schena FP; Pertosa G; Pastore A; Manno C; Pastore G
    Life Support Syst; 1985; 3(1):83-5. PubMed ID: 3990357
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemofiltration--a new method for the purification of blood.
    Quellhorst E; Schuenemann B; Doht B
    Artif Organs; 1978 Feb; 2(1):83-4. PubMed ID: 687023
    [No Abstract]   [Full Text] [Related]  

  • 12. [Determination of clearance for urea-controlled hemodialysis].
    Ahrenholz P; Holtz M; Falkenhagen D; Klinkmann H
    Z Urol Nephrol; 1988 Jul; 81(7):455-66. PubMed ID: 3176721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The use of an ultrafiltration control monitor in patients treated with intermittent hemodialysis (proceedings)].
    Rottembourg J; Jacq D; Durande JP; Rojas P
    J Urol Nephrol (Paris); 1979; 85(4-5):340. PubMed ID: 480451
    [No Abstract]   [Full Text] [Related]  

  • 14. Prostacyclin and heparin during haemodialysis: comparative effects.
    Camici M; Evangelisti L
    Life Support Syst; 1986; 4(3):205-9. PubMed ID: 3537544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of hemodiafiltration. I. In vitro transport characteristics of a hollow-fiber blood ultrafilter.
    Colton CK; Henderson LW; Ford CA; Lysaght MJ
    J Lab Clin Med; 1975 Mar; 85(3):355-71. PubMed ID: 1117205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methods for increasing the efficiency of a new dialyzer-membrane oxygenator.
    Landé AJ; Parker B; Subramanian V; Carlson RG; Lillehei CW
    Trans Am Soc Artif Intern Organs; 1968; 14():227-32. PubMed ID: 5701535
    [No Abstract]   [Full Text] [Related]  

  • 17. Middle molecule definition in terms of membrane permeability.
    Klein E
    Artif Organs; 1981; 4 Suppl():46-50. PubMed ID: 7295095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reinforced cellulose acetate dialysis membranes.
    Mason NS; Lindan O; Sparks RE
    Trans Am Soc Artif Intern Organs; 1968; 14():31-5. PubMed ID: 5701551
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase one clinical trial of a new composite artificial kidney: a single unit combining dialysis with hemoperfusion.
    Chang TM; Barre P; Kuruvilla S; Messier D; Man N; Resurreccion E
    Trans Am Soc Artif Intern Organs; 1982; 28():43-8. PubMed ID: 7164276
    [No Abstract]   [Full Text] [Related]  

  • 20. [Highly effective short-term dialysis using 2 parallel-connected capillary dialysators type C-DAK4. 1. Clearances, efficiency and ultrafiltration].
    Marx M; Schmidt U; Thieler H; Köhler P
    Z Urol Nephrol; 1976 Dec; 69(12):885-95. PubMed ID: 1014931
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.